During astrogliosis or brain-related injury, GFAP is excreted into the circulation [12, 24], thus being a good biomarker of traumatic brain injury (TBI) [38], MS [39, 40], dementia [41, 42], brain tumors [43–45], and other neurological diseases [46]. Here, GFAP is linked to dementia.